I’d buy these 5 FTSE 100 stocks in 2021 to achieve financial freedom

I believe the best way to achieve financial freedom is to build a balanced portfolio of FTSE 100 stocks offering income and growth in 2021 and beyond.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

As the year draws to a close, I’m drawing up a hit list of top FTSE 100 stocks to build my wealth in 2021 and beyond. This year has been tough for investors, but Covid-19 vaccines now promise a brighter future.

There are still plenty of bargain FTSE 100 stocks out there. I think these three should give me the dividend income and share price I’m after to achieve financial freedom and retire at a time of my choosing.

My first pick is FTSE 100 ‘big pharma’ stock GlaxoSmithKline (LSE: GSK). AstraZeneca has dominated the headlines lately, following its Oxford vaccine breakthrough, but Glaxo looks the superior dividend stock today, I feel.

Today, Glaxo yields 5.77%, and unlike many FTSE 100 stocks has maintained shareholder payouts throughout the pandemic. Chief executive Emma Walmsley may have held the dividend at 80p for five years, now, but I’m not complaining given that yield. 

The Glaxo share price has fallen by around a fifth in recent months and I reckon this gives me a great buying opportunity. Today, it trades at just 11.1 times earnings. Believe me, that is cheap for Glaxo. Usually I would consider myself lucky to buy it at 15 times. 

I’d buy these FTSE 100 stocks in 2021

My next FTSE 100 stock pick is more controversial. Oil giant BP (LSE: BP) is facing an existential threat from the rise of renewables, and the war on climate change. Chief executive Bernard Looney is desperately trying to repurpose BP for the net carbon zero world, and there is no guarantee he will win.

Yet I still believe BP can generate healthy income and growth from its legacy fossil fuel business, while switching to greener forms of energy. In the interim, BP offers a whopping forecast yield of 8.4%, despite halving its dividend in August. 

The BP share price is climbing right now and could rebound further as the world starts travelling again. Brent crude is nudging $50 a barrel and the higher it climbs the better this FTSE 100 stock will perform.

I’ll be crying financial freedom

Asset manager and insurer Legal & General Group (LSE: LGEN) has maintained its income throughout the pandemic, holding its nerve even as rival Aviva slashed its payout. Today, it offers investors a juicy forward yield of 6.9%, covered 1.6 times by earnings.

The L&G share price has jumped almost 40% in the last month, which I’m glad to see, given that I have been tipping the stock for years. So it’s not as cheap as it was, but this FTSE 100 stock still looks nicely priced, trading at 8.63 times earnings.

Legal & General has shown its resilience through what should have been a tough year for asset managers. The combination of a low entry price, solid long-term prospects and generous dividend policy makes it a top retirement stock for my portfolio. I’d buy these three in 2021 and move a step closer to achieving financial freedom.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Harvey Jones has no position in any of the shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Bearded man writing on notepad in front of computer
Investing Articles

Could a 2025 penny share takeover boom herald big profits for investors?

When penny share owners get caught up in a takeover battle, what might happen? Christopher Ruane looks at some potential…

Read more »

Young woman working at modern office. Technical price graph and indicator, red and green candlestick chart and stock trading computer screen background.
Investing Articles

3 value shares for investors to consider buying in 2025

Some value shares blew the roof off during 2024, so here are three promising candidates for investors to consider next…

Read more »

Investing Articles

Can this takeover news give Aviva shares the boost we’ve been waiting for?

Aviva shares barely move as news of the agreed takeover of Direct Line emerges. Shareholders might not see it as…

Read more »

Investing Articles

2 cheap FTSE 250 growth shares to consider in 2025!

These FTSE 250 shares have excellent long-term investment potential, says Royston Wild. Here's why he thinks they might also be…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

Has the 2024 Scottish Mortgage share price rise gone under the radar?

The Scottish Mortgage share price rise has meant a good year for the trust so far, but not as good…

Read more »

Investing Articles

Will the easyJet share price hit £10 in 2025?

easyJet has been trading well with rising earnings, which reflects in the elevated share price, but there may be more…

Read more »

Investing Articles

2 FTSE shares I won’t touch with a bargepole in 2025

The FTSE 100 and the FTSE 250 have some quality stocks. But there are others that Stephen Wright thinks he…

Read more »

Dividend Shares

How investing £15 a day could yield £3.4k in annual passive income

Jon Smith flags up how by accumulating regular modest amounts and investing in dividend shares, an investor can build passive…

Read more »